Differential in vitro expression of the brkA gene in Bordetella pertussis and Bordetella parapertussis clinical isolates

Journal of Clinical Microbiology

Volumn 44, Issue 9, 2006, Pages 3397-3400

  Stefanelli, Paola ^a   Sanguinetti, Maurizio ^b   Fazio, Cecilia ^a   Posteraro, Brunella ^b   Fadda, Giovanni ^b   Mastrantonio, Paola ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; BRKA GENE; COMPLEMENT DEPOSITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOCOMPETENCE; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERTUSSIS; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM;

BACTERIAL OUTER MEMBRANE PROTEINS; BLOOD BACTERICIDAL ACTIVITY; BORDETELLA INFECTIONS; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; HUMANS; INFANT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WHOOPING COUGH;

BORDETELLA; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS;

EID: 33748761420     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00247-06     Document Type: Article

References (16)

1. Barnes, M. G., and A. A. Weiss. 2001. BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infect. Immun. 69:3067-3072.
2. Bjornstad, O. N., and E. T. Harvill. 2005. Evolution and emergence of Bordetella in humans. Trends Microbiol. 13:355-359.
3. Byrd, D. W., R. M. Roop, H. P. Veit, and G. G. Schurig. 1991. Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis. J. Med. Microbiol. 34:159-165.
4. Elder, K. D., and E. T. Harvill. 2004. Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect. Immun. 72:5919-5924.
5. Fernandez, R. C., and A. A. Weiss. 1994. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect. Immun. 62:4727-4738.
6. Khelef, N., B. Danve, M. J. Quentin-Millet, and N. Guiso. 1993. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect. Immun. 61:486-490.
7. Mattoo, S., and J. D. Cherry. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326-382.
8. Meijerink, J., C. Mandigers, L. van de Locht, E. Tonnissen, F. Goodsaid, and J. Raemaekers. 2001. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. J. Mol. Diagn. 3:55-61.
9. Peirson, S. N., J. N. Butler, and R. G. Foster. 2003. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 31:e73.
10. Sanguinetti, M., B. Posteraro, B. Fiori, S. Ranno, R. Torelli, and G. Fadda. 2005. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob. Agents Chemother. 49:668-679.
11. Watanabe, M., and M. Nagai. 2001. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect. Immun. 69:6981-6986.
12. Weingart, C. L., W. A. Keitel, K. M. Edwards, and A. A. Weiss. 2000. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect. Immun. 68:7175-7179.
13. Weingart, C. L., and A. A. Weiss. 2000. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect. Immun. 68:1735-1739.
14. Weiss, A. A., P. S. Mobberley, R. C. Fernandez, and C. M. Mink. 1999. Characterization of human bactericidal antibodies to Bordetella pertussis. Infect. Immun. 67:1424-1431.
15. Weiss, A. A., A. K. Patton, S. H. Millen, S. J. Chang, J. I. Ward, and D. I. Bernstein. 2004. Acellular pertussis vaccines and complement killing of Bordetella pertussis. Infect. Immun. 72:7346-7351.
16. Yuk, M. H., E. T. Harvill, and J. F. Miller. 1998. The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol. Microbiol. 28:945-959.